Strategic partnerships Fox Chase Cancer Center collaborates with national leaders and industry partners, including recent clinical trial collaborations with Labcorp and technology partnerships with Omniscope, presenting opportunities for co-development, data sharing, and joint education programs.

Clinical excellence As an NCI-designated comprehensive cancer center with Nobel laureates and a large team of cancer specialists, Fox Chase attracts high-value referrals and potential premium service offerings, such as specialized diagnostics, immunotherapy trials, and multidisciplinary care programs.

Technology affinity The center utilizes modern digital tools and platforms (PWA, JSON-LD, Cloudflare, GTM) and maintains a focus on innovative research translation, signaling openness to vendor solutions in data analytics, patient engagement, and health IT integrations.

Expansion & outreach Recent initiatives include a dedicated young adult cancer program and ongoing conference participation, indicating a growth mindset and opportunities to provide support services, education platforms, and population-specific care enhancements.

Clinical trials access With revenue scale and a strong research base, Fox Chase is positioned for expanded trial collaborations, biobanking partnerships, and laboratory services, appealing to vendors in diagnostics, biomarker testing, and trial supply management.